This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abnova
product type :
antibody
product name :
PTPRC monoclonal antibody, clone BRA-55
catalog :
MAB5305
quantity :
1 mL
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
reactivity :
human
application :
immunoprecipitation, immunohistochemistry - paraffin section, immunohistochemistry - frozen section
product information
catalog id :
MAB5305
product name :
PTPRC monoclonal antibody, clone BRA-55
product description :
Mouse monoclonal antibody raised against native PTPRC.
clone name :
BRA-55
isotype :
IgG1
gene name :
PTPRC
gene alias :
B220 CD45 CD45R GP180 LCA LY5 T200
gene description :
protein tyrosine phosphatase, receptor type, C
immunogen :
Native purified PTPRC from REH6 cell line.
form :
Liquid
recommend dilutions :
Immunohistochemistry (1:10-1:20). The optimal working dilution should be determined by the end user.
storage buffer :
In ascites (0.09% sodium azide)
storage instruction :
Store at 4 C. For long term storage store at -20 C. Aliquot to avoid repeated freezing and thawing.
note :
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
type clonality :
Antibody
raised in host species :
Mouse
antigen species target species :
Human
specificity :
The monoclonal antibody LCA (CD45) is a useful marker to differentiate between lymphomas and carcinomas. Since this monoclonal gives a pronounced staining on formalin fixed paraffin embedded cells it is very useful in routine pathology. Reactive with 170-220 kD cell surface glycoprotein(s).
species reactivity cross reactivity :
Human
application key :
IP,IHC-Fr,IHC-P
size :
1 mL
autodate :
2010-01-04
updatetime :
2015-02-05 13:43:19
company information
Abnova
9th Fl., No.108, Jhouzih St.
Neihu District. Taipei City
114 Taiwan
Neihu District. Taipei City
114 Taiwan
sales@abnova.com
https://www.abnova.com877-853-6098
questions and comments